Abbott Laboratories (ABT) Enterprise Value (EV): $229 Billion

Since December 31st, 2007, Abbott Laboratories's enterprise value (ev) has increased from $37.5 Billion to $229 Billion at January 26th, 2022.

From 2007 to 2022 Abbott Laboratories's highest enterprise value (ev) was $259 Billion
Abbott Laboratories's lowest enterprise value (ev) during that period was $28 Billion
Abbott Laboratories's average enterprise value (ev) from 2007 to 2022 Abbott Laboratories's was $85.6 Billion

Abbott Laboratories's enterprise value (ev) as of January 26th, 2022 of $229 Billion was higher than its peers in the Medical Appliances & Equipment industry group of December 31st, 2021 of 5.26 Billion. From December 31st, 2007 to January 26th, 2022, Abbott Laboratories's average enterprise value (ev) was 85.6 Billion compared to an industry average of 330 Billion.

About Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure and other medical device products. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.